We are live on ! Find out more
KTOVW

Kitov Pharma Ltd. Warrants
KTOVW

Delisted

KTOVW was delisted on the 23rd of November, 2020.

Back to rankings

4 hedge funds and large institutions have $1.04M invested in Kitov Pharma Ltd. Warrants in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

198% more capital invested

Capital invested by funds: $350K → $1.04M (+$694K)

0% more funds holding

Funds holding: 4 → 4 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$1.62M
2
Wells Fargo
Wells Fargo
California
+$2.95K

Top Sellers

Rank Fund Capital Flow
1
ICM
Ionic Capital Management
New York
-$95.5K
2
BA
BlackRock Advisors
Delaware
-$8.02K
3
UBS Group
UBS Group
Switzerland
-$5K

KTOVW Hedge Fund Activity: Q2 2016 in Review

4 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Kitov Pharma Ltd. Warrants (KTOVW) for Q2 2016, worth a combined $1.04M — up 198% from $350K a quarter earlier.

Fund positioning in KTOVW was balanced in Q2 2016: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was Sabby Management, adding an estimated $1.62M. The largest seller was Ionic Capital Management, cutting an estimated $95.5K.

  • 4 institutional investors held Kitov Pharma Ltd. Warrants (KTOVW) as of Q2 2016, unchanged from Q1 2016.
  • Funds reported $1.04M of Kitov Pharma Ltd. Warrants stock for Q2 2016, up 198% quarter-over-quarter.
  • 1 fund opened new Kitov Pharma Ltd. Warrants positions in Q2 2016 and 1 closed out, a net change of 0 holders.
  • The largest Kitov Pharma Ltd. Warrants buyer in Q2 2016 was Sabby Management, an estimated $1.62M added.
  • The largest Kitov Pharma Ltd. Warrants seller in Q2 2016 was Ionic Capital Management, an estimated $95.5K sold.

Based on aggregated 13F filings for Q2 2016.